US Patent Issued to Phytovent Biopharma on Oct. 21 for "Derivative of sarsasapogenin, pharmaceutical composition and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,410, issued on Oct. 21, was assigned to Phytovent Biopharma (Shenzhen, China).

"Derivative of sarsasapogenin, pharmaceutical composition and use thereof" was invented by Shawn Mu (Shenzhen, China) and Na Wang (Shenzhen, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A derivative of sarsasapogenin is provided having a structure of formula I,A pharmaceutical composition of the aforementioned derivative of sarsasapogenin and use thereof are also provided. By systematic modification and derivatization of sarsasapogenin structure in combination with inhibitory activity assays on tumor cells, many derivative compounds are provided that have excellen...